CG
BEAT

Cutler Group’s BioTelemetry, Inc. BEAT Stock Holding History

Cutler Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500
Closed -$1K – 6670
2020
Q4 		$1K Buy
+500
New +$26.2K ﹤0.01% 4703
2019
Q1 		– Sell
-5,000
Closed -$55K – 5180
2018
Q4 		$55K Hold
5,000
– – 0.01% 1424
2018
Q3 		$86K Sell
5,000
-500
-9% -$27.9K 0.01% 1292
2018
Q2 		$21K Buy
+5,500
New +$219K ﹤0.01% 2178
2017
Q4 		– Sell
-400
Closed -$2K – 6674
2017
Q3 		$2K Hold
400
– – ﹤0.01% 5289
2017
Q2 		$1K Sell
400
-7,400
-95% -$221K ﹤0.01% 6230
2017
Q1 		$25K Buy
7,800
+4,400
+129% +$109K ﹤0.01% 3124
2016
Q4 		$5K Buy
3,400
+3,100
+1,033% +$60.6K ﹤0.01% 5026
2016
Q3 		$1K Buy
+300
New +$5.66K ﹤0.01% 6526
2016
Q1 		– Sell
-10,100
Closed -$2K – 7903
2015
Q4 		$2K Buy
+10,100
New +$128K ﹤0.01% 5790

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Cutler Group's BEAT Position: Q1 2020 in Review

Cutler Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 1,600 shares — an estimated $74K sold.

Cutler Group first reported a position in BEAT in Q1 2016 and held it in 11 quarters. The position peaked at $426K in Q2 2017. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

  • Cutler Group reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 1,600 BioTelemetry, Inc. shares in Q1 2020, an estimated $74K.
  • Cutler Group first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 11 quarters.
  • Cutler Group's BioTelemetry, Inc. position peaked at $426K in Q2 2017.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.